We are live on
!
Find out more
CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
192 hedge funds and large institutions have $3.27B invested in Clovis Oncology, Inc. in 2015 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 88 increasing their positions, 45 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
96% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 45
71% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 24
18% more capital invested
Capital invested by funds: $2.76B → $3.27B (+$507M)
9% more funds holding
Funds holding: 176 → 192 (+16)
0% more funds holding in top 10
Funds holding in top 10: 13 → 13 (0)
4% less call options, than puts
Call options by funds: $49.6M | Put options by funds: $51.5M
Holders
192
Holders Change
+16
Holders Change %
+9.09%
% of All Funds
5.36%
Holding in Top 10
13
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.36%
New
41
Increased
88
Reduced
45
Closed
24
Calls
$49.6M
Puts
$51.5M
Net Calls
-$1.96M
Net Calls Change
+$955K
Top Buyers
| 1 |
AA
Antipodean Advisors
New York
|
+$113M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$72.4M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$61.2M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$52.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$36.1M |
